GlassScriptPhysician profile
John Anthony Forcella
NPI 1639317639
$6,642.55
in general payments reported to CMS, 2019-2025
38 companies · $1,861 in 2025
The $1,861 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,893 · 2020: $352 · 2021: $199 · 2022: $333 · 2023: $850 · 2024: $1,154 · 2025: $1,861.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,753 · Education: $98.99 · Travel and Lodging: $13.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,752.87 |
| Education | $98.99 |
| Travel and Lodging | $13.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $931.18 | 2020-2025 | Lifevest |
| Medtronic Vascular, INC. | $487.93 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $479.16 | 2021-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $467.34 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $422.43 | 2019-2025 | |
| Endologix LLC | $375.28 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $343.99 | 2019-2024 | Farxiga |
| Inari Medical, INC. | $321.41 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boehringer Ingelheim Pharmaceuticals, INC. | $274.87 | 2019-2025 | Jardiance |
| Abiomed | $267.08 | 2024-2025 | Impella |
| Scpharmaceuticals INC. | $215.94 | 2024-2025 | |
| Janssen Scientific Affairs, LLC | $210.09 | 2019-2020 | |
| Lexicon Pharmaceuticals, INC. | $206.09 | 2023-2024 | Inpefa |
| Abbott Laboratories | $188.65 | 2019-2025 | Perclose Prostyle |
| Actelion Pharmaceuticals US, INC. | $172.93 | 2024-2025 | Opsumit, Uptravi |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $165.77 | 2024-2025 | Avvigo Guidance System, Cds - Mct/Cem Monitoring, Watchman Flx |
| Pfizer INC. | $142.05 | 2019-2025 | |
| Alnylam Pharmaceuticals INC. | $110.84 | 2024-2025 | Onpattro |
| Ekos Corporation | $96.50 | 2019 | |
| Amgen INC. | $92.87 | 2019-2025 | Repatha, Repatha, Otezla |
| Shockwave Medical, INC | $87.92 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $85.83 | 2025 | |
| Philips North America LLC | $68.59 | 2022-2023 | |
| Amarin Pharma, INC. | $62.79 | 2021 | |
| Sanofi-Aventis U.S. LLC | $39.75 | 2019 | |
| Novo Nordisk INC | $37.13 | 2020-2023 | Wegovy |
| Medtronic, INC. | $33.86 | 2023 | Corevalve Evolut R |
| Bridgebio Pharma, INC. | $33.63 | 2025 | Attruby |
| Atricure, INC. | $32.69 | 2023 | |
| Irhythm Technologies, INC. | $29.92 | 2024 | Zio Monitor, Zio Xt Patch |
| Cardiovascular Systems INC. | $25.24 | 2022 | |
| Abbvie INC. | $21.80 | 2023 | |
| Lilly USA, LLC | $21.02 | 2025 | Zepbound |
| Preventice Services, LLC | $20.34 | 2020 | |
| Kiniksa Pharmaceuticals, LTD. | $18.77 | 2023 | Arcalyst |
| Kestra Medical Technology Services, INC. | $18.59 | 2025 | Assure Wcd |
| Kiniksa Pharmaceuticals International, Plc | $17.74 | 2024 | Arcalyst |
| Lifescan, INC. | $14.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Forcella listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.